E. Gunji

发表

DMD058305 1456..1465

S. Jingu, Saeko Uchida, S. Sakai, 2014 .

Absorbed via an Intestinal Transporter in Humans

S. Jingu, Saeko Uchida, S. Sakai, 2014 .

A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans

S. Jingu, Saeko Uchida, S. Sakai, 2014, Drug Metabolism and Disposition.

SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP‐1 and GLP‐2 secretion in rats

F. Io, Hiroko Koretsune, Saeko Uchida, 2019, European journal of pharmacology.

TS‐071 is a novel, potent and selective renal sodium‐glucose cotransporter 2 (SGLT2) inhibitor with anti‐hyperglycaemic activity

S. Uchida, H. Tomoike, K. Yamamoto, 2011, British journal of pharmacology.

Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1' Subsite Binder with Short Peptides.

M. Yashiro, A. Mitani, E. Gunji, 2022, Journal of medicinal chemistry.

In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies.

Saeko Uchida, Koji Yamamoto, Teisuke Takahashi, 2015, Journal of pharmacological sciences.

In vivo microdialysis measurement of histamine in rat blood effects of compound 48/80 and histamine receptor antagonists.

T. Watanabe, K. Maeyama, Y. Iizuka, 1993, Journal of pharmacological and toxicological methods.

Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.

H. Kakinuma, Hiroko Koretsune, Yuji Ito, 2022, Journal of medicinal chemistry.

Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis.

Mayumi Endo, E. Gunji, Harumi Kanazawa, 2023, Journal of medicinal chemistry.